BR100 Increased By (0.39%)
BR30 Increased By (0.47%)
KSE100 Increased By (0.6%)
KSE30 Increased By (0.7%)
AGHA 6.55 Increased By ▲ 0.23 (3.64%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.43 Decreased By ▼ -0.02 (-0.03%)
BOP 31.38 Increased By ▲ 0.15 (0.48%)
CNERGY 11.79 Increased By ▲ 0.20 (1.73%)
CSIL 5.95 Increased By ▲ 0.23 (4.02%)
FCCL 61.12 Decreased By ▼ -0.42 (-0.68%)
FFL 14.88 Decreased By ▼ -0.14 (-0.93%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.29 Increased By ▲ 0.03 (0.48%)
KOSM 6.00 Increased By ▲ 0.44 (7.91%)
LOTCHEM 24.85 Increased By ▲ 0.17 (0.69%)
MLCF 104.13 Increased By ▲ 0.05 (0.05%)
NBP 174.66 Decreased By ▼ -0.62 (-0.35%)
NCPL 52.83 Increased By ▲ 0.06 (0.11%)
NPL 54.48 Increased By ▲ 0.36 (0.67%)
OGDC 315.35 Increased By ▲ 1.96 (0.63%)
PACE 9.41 Increased By ▲ 0.21 (2.28%)
PAEL 35.62 Decreased By ▼ -0.18 (-0.5%)
PIBTL 13.71 Increased By ▲ 0.24 (1.78%)
PPL 223.38 Increased By ▲ 1.57 (0.71%)
PRL 80.79 Increased By ▲ 1.71 (2.16%)
PTC 47.15 Increased By ▲ 0.30 (0.64%)
SSGC 24.15 Increased By ▲ 0.28 (1.17%)
TBL 9.25 Decreased By ▼ -0.06 (-0.64%)
TELE 7.53 Increased By ▲ 0.14 (1.89%)
TPL 24.89 Decreased By ▼ -0.22 (-0.88%)
TPLP 12.88 Increased By ▲ 0.37 (2.96%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 53.75 Increased By ▲ 0.31 (0.58%)
World

Cuba to collaborate with Iran on coronavirus vaccine

  • The allies are both under fierce US sanctions that exempt medicine yet often put foreign pharmaceutical companies off trading with them and as such they seek to be self-reliant.
  • Iran launched human trials of its first domestic COVID-19 vaccine candidate late last month, while Cuba has four candidates currently in trials although none yet in humans.
Published Updated
By

HAVANA: Communist-run Cuba said late on Friday it had signed an accord with Iran to transfer the technology for its most advanced coronavirus vaccine candidate and carry out last-stage clinical trials in humans of the shot in the Islamic Republic.

The allies are both under fierce US sanctions that exempt medicine yet often put foreign pharmaceutical companies off trading with them and as such they seek to be self-reliant. Both are also strapped for cash.

Iran launched human trials of its first domestic COVID-19 vaccine candidate late last month, while Cuba has four candidates currently in trials although none yet in humans.

Once its most advanced candidate, Soberana (Sovereign) 2, has completed Phase II trials which started on Dec. 22, it will be tested in human trials in around 150,000 people in Havana, officials have said.

Yet the Caribbean country will need to conduct more human trials abroad too given it does not have a high infection rate due to its successful management of its outbreak, they said. Iran, meanwhile, has been the worst-hit country in the Middle East.

Cuba's Finlay Vaccine Institute said late on Friday it has signed an accord with Iran's Pasteur Institute to collaborate on testing of Soberana 2.

"This synergy will enable both countries to advance more rapidly in the immunization against the SARS-CoV-2 virus," it said on its Twitter account.

Cuba says several countries have expressed interest in its coronavirus vaccines but this is the first such accord it has reached.

Health Ministry spokesman Kianush Jahanpur was cited by Iranian media as saying 50,000 volunteers would be recruited to carry out the Phase III clinical trials. Technology transfer and joint production were preconditions for allowing human testing in the country, he said.

Iran Foreign Minister Javad Zarif said he was "impressed" by the biotech achievements of its old ally Cuba in the fight against COVID-19 during a visit to Havana on a Latin American tour last November.

In addition to developing its own vaccine, Iran is participating in the COVAX scheme which aims to secure fair access to COVID-19 vaccines for poorer countries. Yet its Supreme Leader on Friday banned the government from importing COVID-19 vaccines from the United States and Britain, labeling the Western powers "untrustworthy."

Cuba has not talked of importing vaccines from elsewhere and said it intends to start vaccinating its population against COVID-19 with its own vaccine in the first half of the year.

Comments

Comments are closed for this article.